KOBENHAVNS UNIVERSITET
Patent Owner
Stats
- 19 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Nov 14, 2017 most recent publication
Details
- 19 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 319 Total Citation Count
- Dec 06, 2000 Earliest Filing
- 24 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9815876 Chimeric inhibitor molecules of complement activationMar 04, 11Nov 14, 17[A61K, A01N, C12P, A61P, C07K]
9660721 Optical detector and amplifier for RF-detection having a position dependent capacitor with a displaceable membraneJul 11, 14May 23, 17[H04B]
9572365 Bovine colostrum as minimal enteral nutrition for preterm infantsJun 07, 13Feb 21, 17[A61K, A23L]
9573984 Chimeric inhibitor molecules of complement activationDec 30, 14Feb 21, 17[A61K, C12P, A61P, C07K]
9491958 Process for the manufacture of a product from a plant materialMar 01, 12Nov 15, 16[A23L, A23J]
9388389 JFH-1 based HCV cell culture systems for NS5A of genotypes 1-7Oct 01, 10Jul 12, 16[A61K, C12Q, C12N, G01N, C07K]
8912311 Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodiesApr 16, 13Dec 16, 14[A61K, G01N, C07K]
8846891 Infectious genotype 1a, 1b, 2a, 2b, 3a, 5a, 6a and 7a hepatitis C virus lacking the hypervariable region 1 (HVR1)Aug 07, 09Sep 30, 14[A61K, C12N, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0234,294 Fibroblast Growth Factor Receptor-Derived Peptides Binding to NCAMAbandonedDec 24, 13Aug 21, 14[C07K]
2014/0235,576 PYRROLIDINE-2-CARBOXYLIC ACID DERIVATIVES AS IGLUR ANTAGONISTSAbandonedFeb 14, 14Aug 21, 14[C07F, C07D]
8637465 Fibroblast growth factor receptor-derived peptides binding to NCAMExpiredMay 27, 09Jan 28, 14[A61K]
2012/0258,515 Cytolytic RTX-Toxin From Gallibacterium AnatisAbandonedOct 07, 10Oct 11, 12[C12N, C07K]
2012/0128,770 TREATMENT OF INSULIN RESISTANCE AND OBESITY BY STIMULATING GLP-1 RELEASEAbandonedJun 24, 10May 24, 12[A61K, C12N, C07C, A61P]
2012/0021,937 DETECTION OF CARCINOMA IN SITU IN SEMEN SPECIMENSAbandonedOct 08, 09Jan 26, 12[C12Q, G01N, C40B]
2011/0111,023 PREVENTION OF TYPE 1 DIABETES BY ADMINISTRATION OF GLIADINAbandonedSep 10, 08May 12, 11[A61K, A61P, C07K]
2011/0004,453 METHOD FOR PREDICTION OF LIPOPROTEIN CONTENT FROM NMR DATAAbandonedJun 24, 10Jan 06, 11[G06F, G06G]
2009/0307,788 RIBOZYME MEDIATED STABILIZATION OF POLYNUCLEOTIDESAbandonedJun 19, 07Dec 10, 09[C07H, A61K, C12P, C12N, A01K, A01H]
2008/0193,440 Method For Multiple Sclerosis Treatment and Prophylaxis By Treatment of Leptospira InfectionAbandonedJun 29, 05Aug 14, 08[A61K, C12Q, G01N]
2007/0276,131 Continuous Process for the Assembly of Macromolecular Substances and the Subsequent Capture and Isolation of Mamacromolecular Assembly and a System Suitable for the ProcessAbandonedAug 12, 04Nov 29, 07[B03C, C07H, C07K]
2007/0157,873 Method of fabrication and device comprising elongated nanosize elementsAbandonedSep 10, 04Jul 12, 07[C30B]
2005/0244,388 Suprabasal breast cell with stem cell propertiesAbandonedJun 29, 05Nov 03, 05[A61K, C12Q, C12N]
2004/0219,551 Epsti1, a novel gene induced by epithelial-stromal interaction in human breast cancerAbandonedJun 08, 04Nov 04, 04[C07H, C12Q, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.